CG Structure · 2025
In this section19 topics
- Board Composition9 items
- Board of Directors1 item
- Board Meetings & Remuneration5 items
- Balance of Power Between the Board and Management3 items
- Board Roles, Duties and Charter3 items
- Other Board Governance Matters1 item
- Audit Committee4 items
- Executive Committee4 items
- Other Subcommittees1 item
- Executives2 items
- Executive Remuneration4 items
- Remuneration Policy2 items
- Employees1 item
- Provident Fund1 item
- Policy for Employees Not in the Provident Fund4 items
- Auditors and Audit Fees4 items
- Company Secretary and Other Assigned Persons3 items
- Investor Relations Contact3 items
- Representatives in Thailand (Foreign Companies)1 item
Board Composition
Board Composition — Introduction
The composition of the company's board of directors is diverse in terms of work experience and education, including a proportion of independent directors exceeding one-third, and non-executive directors constituting more than half of all directors. This structure is designed to enable independent decision-making as representatives of all shareholders and to ensure an effective balance of power in management.
Total Number of Directors
7
Male Directors
7
Female Directors
0
Independent Directors
3
Non-executive Directors
4
Non-executive Directors Who Are Not Independent
1
Executive Directors
3
Total Board Meetings Held
8
Board of Directors
Directors
| Title | Title — Please Specify | First Name | Last Name | Gender | Year of Birth | Nationality | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Director Type | Appointment Date | Authorised to Sign? | Related to Another Director or Executive? | Any Legal Violation in the Past 5 Years? | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Director Training | Attended Director Training? | Director Accreditation Program (DAP)? | Director Certification Program (DCP)? | Board Meetings Held | Board Meetings Attended | AGMs Held | AGMs Attended | Meeting Allowance (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Assistant Professor Dr. | Wanchai | Sutananta | M | 1,960 | 643 · Description: Thailand | Y | Chairman of the board | Non-executive | Y | Existing director | 2020-12-09T00:00 | N | N | N | Doctoral degree | other | Pharmacist | 158 · Description: Corporate Management · 164 · Description: Strategic Management · 162 · Description: Change Management · 163 · Description: Leadership · 3173 · Description: Public Administration | N | Y | N | 8 | 8 | 1 | 1 | 390,000 | 390,000 | 0 | |
| other | Pharmacist | Worathep | Gorgitpoonpol | M | 1,959 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2020-12-09T00:00 | N | N | N | Bachelor's degree | other | Pharmacy | 142 · Description: Marketing · 117 · Description: Personal Products & Pharmaceuticals · 158 · Description: Corporate Management · 162 · Description: Change Management · 1683 · Description: Business Administration | N | Y | N | 8 | 8 | 1 | 1 | 200,000 | 200,000 | 0 | |
| other | Dr. | Thanadol | Ruksapol | M | 1,983 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2020-12-09T00:00 | N | N | N | Doctoral degree | Accounting | 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 166 · Description: Audit · 167 · Description: Internal Control | 2025 · Description: Board Orientation for New Listed Companies | Y | Y | N | 8 | 8 | 1 | 1 | 200,000 | 200,000 | 0 | |
| other | Pharmacist | Suvit | Ngampoopun | M | 1,962 | 643 · Description: Thailand | Y | Director | Executive | Continuing director (Full term of directorship and being re-appointed as a director) | 1992-10-16T00:00 | Y | Y | N | Master's degree | Business Administration | 142 · Description: Marketing · 164 · Description: Strategic Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals · 163 · Description: Leadership | N | Y | N | 8 | 8 | 1 | 1 | 0 | |||||
| other | Pharmacist | Subhachai | Saibour | M | 1,958 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 1992-10-16T00:00 | Y | N | N | Bachelor's degree | other | Pharmaceutical Sciences | 1683 · Description: Business Administration · 158 · Description: Corporate Management · 117 · Description: Personal Products & Pharmaceuticals · 145 · Description: Corporate Social Responsibility · 164 · Description: Strategic Management | N | Y | N | 8 | 8 | 1 | 1 | 0 | ||||
| other | Pharmacist | Somchai | Phisphahutharn | M | 1,960 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 1992-10-16T00:00 | Y | N | N | Master's degree | Science | 143 · Description: Accounting · 144 · Description: Finance · 117 · Description: Personal Products & Pharmaceuticals · 158 · Description: Corporate Management · 165 · Description: Risk Management | 2025 · Description: TLCA - CFO Professional Development Program (TLCA CFO CPD) 1/2025 : “Economic Update for CFO” · 2025 · Description: TLCA - CFO Professional Development Program (TLCA CFO CPD) 2/2025 : “Digital Asset: Utility Token” · 2025 · Description: TLCA - CFO Professional Development Program (TLCA CFO CPD) 3/2025: “Update! IFRS 18 IFRS 19” · 2025 · Description: TLCA - CFO Professional Development Program (TLCA CFO CPD) 5/2025 : "Accounting System Setup" · 2025 · Description: SET - CFO Annual Conference on Capital Markets | Y | Y | Y | 8 | 7 | 1 | 1 | 0 | ||||
| Mr. | Surasilp | Ngampoopun | M | 1,992 | 643 · Description: Thailand | Y | Director | Non-executive | N | Existing director | 2020-12-09T00:00 | N | Y | N | Bachelor's degree | other | Marketing | 142 · Description: Marketing · 154 · Description: Digital Marketing · 1683 · Description: Business Administration · 155 · Description: Brand Management · 164 · Description: Strategic Management | N | Y | N | 8 | 7 | 1 | 1 | 0 |
Board Meetings & Remuneration
Board Meetings — Introduction
Authorized signatories of the company
The authorized signatories of the company are Mr. Suvit Ngamphuphan, Mr. Somchai Pisapahutharn, and Mr. Subhachai Saibua. Two out of three signatories must sign jointly with the company's seal.
Reservation of rights for matters requiring Board of Directors' approval
The Board of Directors reserves the right to approve significant matters to protect the best interests of the company and its shareholders, such as:
Strategies, business plans, and annual budgets
Expenses exceeding the limit that sub-committees or executives are authorized to approve
Investments in new businesses and divestments
Important Policies - Entering into significant contracts
Significant lawsuits and legal proceedings
Dividend payment policy
Date of the Annual General Meeting
2024-04-01T00:00
Was an Extraordinary General Meeting Held?
No
Board Meeting Allowance (Baht)
790000.0
Total Board Remuneration (Baht)
790000.0
Balance of Power Between the Board and Management
Are There Measures Balancing the Board's and Management's Power?
Yes
Measures Balancing the Board's and Management's Power
Measures and methods for balancing power between the Board of Directors and management.
The positions of Chairman and Chief Executive Officer must not be held by the same person to ensure appropriate balance of power and duties.
The Chairman is Asst. Prof. Dr. Wanchai Sutthana-nant, an independent director, and is not the same person as the Chief Executive Officer, nor do they have any blood or business relationship. The separation of positions and responsibilities of the Chairman and the Chief Executive Officer is clearly defined in the good corporate governance policy.
Scope of authority, duties, and responsibilities of the Chairman.
1. The Chairman is appointed by the Board of Directors to hold the position of Chairman of the company. The person holding the position of Chairman must be an independent director and must not be the same person as the Chief Executive Officer or an equivalent position with a different name.
2. Supervise, monitor, and support the efficient performance of the Board of Directors' duties and the achievement of the organization's main objectives and goals.
3. The Chairman or a person assigned by the Chairman is responsible for calling Board of Directors' meetings and encouraging directors to attend Board of Directors' meetings.
4. The Chairman plays a role in determining the agenda for Board of Directors' meetings, in consultation with the Chief Executive Officer and/or management, and has measures to ensure that important matters are included in the agenda.
5. In cases where the Chairman is not an independent director, the Chairman and the Chief Executive Officer are members of the same family, or the Chairman is a member of the executive committee or working group or has been assigned management responsibilities, the Board of Directors shall appoint one independent director to jointly consider and determine the agenda for Board of Directors' meetings, in order to comply with good corporate governance principles.
6. To act as chairman of the Board of Directors' meeting to conduct the meeting in accordance with the agenda, the company's articles of association, and relevant laws, including controlling the meeting efficiently, allocating sufficient time for management or relevant parties to present supporting information, and providing opportunities for directors to ask questions and express opinions freely, controlling discussion points, and summarizing meeting resolutions.
7. To act as chairman of the shareholders' meeting to conduct the meeting in accordance with the agenda, the company's articles of association, and relevant laws, including controlling the meeting efficiently, allocating appropriate time, providing opportunities for shareholders to ask questions and express opinions equally, and ensuring that shareholders' questions are answered.
8. Encourage all directors to participate in promoting an ethical organizational culture and good corporate governance.
9. Promote directors' performance of duties within the scope of authority, duties, and responsibilities of the Board of Directors and relevant laws, including adherence to corporate governance principles.
good practices, such as abstaining from voting and leaving the meeting room when an agenda item where a director has a conflict of interest is being considered.
10. Promote good relationships between executive and non-executive directors, and between the Board of Directors and management.
11. Communicate various important information to the Board of Directors.
Scope of authority, duties, and responsibilities of the Chief Executive Officer.
1. Operate, manage, and oversee the overall operations of the company to comply with its objectives, articles of association, policies, regulations, requirements, orders, business strategies, goals, operational plans, financial targets, budgets, and resolutions of the Board of Directors and/or resolutions of the company's shareholders' meetings.
2. Ensure the preparation and submission of the company's business policies, including work plans and budgets, to the Board of Directors for consideration and approval, and to regularly report progress according to the approved work plans and budgets to the Board of Directors.
3. Operate, manage, and oversee the performance of duties in accordance with the business policies, goals, operational plans, and annual budgets approved by the Board of Directors efficiently and effectively, based on systematic internal control and consistent risk management.
4. Set operational goals, allocate resources to align with business and management policies, and control, inspect, and monitor the performance of management and suggest solutions to various problems to ensure that executives and management implement the planned business strategies in accordance with the company's policies.
5. Determine the organizational structure, management methods, including selection, training, hiring, transfer, and termination of employees, and set wage rates, salaries, remuneration, bonuses, and various benefits for employees, within the scope of the company's regulations.
6. Command, contact, instruct, operate, and sign legal acts, contracts, order documents, notices, or any other documents used to communicate with agencies or other persons, to ensure the efficient and effective operation of the company as assigned and/or authorized by the Board of Directors.
7. Has the authority to sub-delegate and/or assign specific tasks to other persons. Such sub-delegation and/or assignment shall be within the scope of the power of attorney and/or in accordance with the rules, regulations, or orders prescribed by the Board of Directors and/or the Company.
However, the delegation of authority, duties, and responsibilities to the Chief Executive Officer must not be a delegation or sub-delegation that allows the Chief Executive Officer or the authorized person to approve transactions in which they or persons who may have a conflict of interest, have a stake, receive benefits in any manner, or may have other conflicts of interest with the company or its subsidiaries (as defined in the notifications of the Securities and Exchange Commission or the Capital Market Supervisory Board). Such transactions must be presented to the Board of Directors or shareholders for consideration and approval, as the case may be, in accordance with the company's articles of association or relevant laws, unless it is an approval of transactions that are normal general commercial transactions of the company in accordance with the policies and criteria approved by the Board of Directors.
8. To be a leader and act as a role model in accordance with the company's ethical principles and business code of conduct, as well as to promote, supervise, and monitor management based on sustainability principles, good corporate governance, social responsibility, and to comply with anti-corruption measures and practices.
9. Has other powers, duties, and responsibilities as assigned or delegated by the Board of Directors.
Reservation of matters requiring Board of Directors' approval.
The Board of Directors reserves the right to approve important matters to safeguard the best interests of the company and its shareholders, such as (1) strategies, business plans, and annual budgets, (2) expenses exceeding the limits authorized for approval by sub-committees or executives, (3) investments in new businesses and divestments, (4) significant policies, (5) entering into important contracts, (6) significant lawsuits and legal proceedings, and (7) dividend payment policies.
Methods Used to Balance Power
| Method | Other — Please Specify |
|---|---|
| Increasing the proportion of independent directors | |
| Other | The positions of Chairman of the Board and Chief Executive Officer must not be held by the same individual. |
| Appointment of an independent director Participate in determining the meeting agenda for the committee |
Board Roles, Duties and Charter
Board Roles and Duties — Introduction
The Board of Directors represents the shareholders as a whole, not any specific group of shareholders, and sets policies to ensure a fair proportion of directors based on the investment of controlling shareholders. The powers, duties, and responsibilities of the directors shall be as prescribed by law, the company's objectives, articles of association, and resolutions of the shareholders' meeting, including the following actions:
1. Perform duties with responsibility, due care, and integrity, and comply with laws, objectives, company regulations, and resolutions of the shareholders' meeting, except for matters requiring prior approval from the shareholders' meeting before implementation, such as matters legally requiring shareholders' resolution, connected transactions, and significant asset acquisitions or disposals according to the rules of the Stock Exchange of Thailand or as prescribed by other government agencies.
2. Oversee the company's operations to ensure ethical practices, such as establishing corporate governance policies, manuals, and a code of business ethics for directors, executives, and employees of the company, as well as disclosing them, mandating compliance, and monitoring adherence.
3. Consider and approve the company's business policies, goals, operational plans, business strategies, and annual budget, as well as regularly review and revise the appropriateness of various policies on an annual basis.
4. Consider and approve the appointment of individuals who possess the qualifications and do not have the prohibited characteristics as stipulated in the Public Limited Company Act B.E. 2535 (and its amendments) and the Securities and Exchange Act of Thailand, including relevant announcements, regulations, and/or rules, to serve as directors, in cases where a director's position becomes vacant for reasons other than retirement by rotation.
5. Consider appointing independent directors, taking into account their qualifications and prohibited characteristics as stipulated by the Securities and Exchange Act of Thailand, announcements of the Capital Market Supervisory Board, and/or relevant announcements, regulations, and/or rules of the Stock Exchange of Thailand, or propose to the shareholders' meeting for consideration and appointment as independent directors of the company, in accordance with the recommendations of the Nomination and Remuneration Committee.
6. Consider appointing an Audit Committee, with qualifications as stipulated by the Securities and Exchange Act of Thailand, announcements of the Capital Market Supervisory Board, and/or relevant announcements, regulations, and/or rules of the Stock Exchange of Thailand, in accordance with the recommendations of the Nomination and Remuneration Committee.
7. Consider appointing executive directors, selected from the company's directors, executives, or external individuals, and define the scope, authority, duties, and responsibilities of the executive committee, in accordance with the recommendations of the Nomination and Remuneration Committee.
8. Consider appointing other sub-committees to assist in performing the responsibilities of the Board of Directors.
9. Consider and determine, and amend the names of authorized directors who can sign to bind the company.
10. Appoint any other person to conduct the company's business under the control of the Board of Directors, or may delegate authority to such person to exercise powers for a period deemed appropriate by the Board of Directors, which the Board of Directors may revoke, withdraw, alter, or amend such powers.
11. Consider and approve the acquisition or disposal of assets of the company or its subsidiaries, investments in new businesses, and any operations, unless such transactions require approval from the shareholders' meeting. The consideration and approval shall be in accordance with the Securities and Exchange Act, announcements of the Capital Market Supervisory Board, and/or relevant announcements, regulations, and/or rules of the Stock Exchange of Thailand.
12. Consider and approve connected transactions, unless such transactions require approval from the shareholders' meeting. The consideration and approval shall be in accordance with the Securities and Exchange Act, announcements of the Capital Market Supervisory Board, and/or relevant announcements, regulations, and/or rules of the Stock Exchange of Thailand.
13. Consider and approve the payment of interim dividends to shareholders when the company deems it has sufficient profits to do so, and report such dividend payment to the shareholders' meeting at the next shareholders' meeting.
14. Arrange for the preparation of the company's financial statements at the end of the accounting year, audited by an auditor, to be presented to the shareholders' meeting at the annual general meeting for consideration and approval.
15. Arrange for the preparation of the company's financial statements at the end of each quarterly accounting period, reviewed by an auditor.
16. Perform any other duties related to the company's business as assigned by the shareholders.
Term of office for directors
Directors shall hold office for a term of 3 years, and upon completion of their term, may be considered for re-election as directors. Independent directors may serve for a continuous period not exceeding 9 years from the date of their initial appointment as independent directors. In cases where an independent director is to be re-appointed, the Board of Directors should reasonably consider the necessity of such appointment.
At every annual general meeting of shareholders, one-third of the directors in office at that time shall retire. If the number of directors cannot be divided exactly by three, the number closest to one-third shall retire.
For the first and second years after the company's conversion to a public limited company, directors who must retire shall be determined by drawing lots. In subsequent years, the director who has held office for the longest period shall retire. In addition to retirement by rotation, a director may vacate office when
Death
Resignation
Reaches the age of 72, in which case they shall vacate the position of director from the end of the accounting year.
Lacks qualifications to be a director or possesses prohibited characteristics under the Public Limited Company Act and/or the Securities and Exchange Act.
The shareholders' meeting resolves to remove them from office by a vote of not less than three-fourths (3/4) of the shareholders present and entitled to vote, and holding shares totaling not less than one-half of the total shares held.
The court ordered their removal
Any director wishing to resign from their position shall submit a letter of resignation to the Chairman of the Board.
In the event that a director's position becomes vacant for reasons other than retirement by rotation, the Board of Directors, upon the recommendation of the Nomination and Remuneration Committee, shall appoint a qualified person without prohibited characteristics as specified in clause 3 above to fill the vacancy at the next Board meeting, with a vote of not less than three-fourths of the remaining directors. However, if the term of office for that director is less than 2 months, the Board of Directors may choose not to appoint a replacement director. Any replacement director appointed shall hold office only for the remainder of the term of the director they replace.
Does the Company Have a Board Charter?
Yes
Content of the Board Charter
The Board of Directors is responsible for setting the direction, policies, and business strategies, and for overseeing the management's operations to ensure compliance with established policies, for the utmost benefit of the company and its shareholders under the principles of good corporate governance.
Other Board Governance Matters
Board Governance Practices
| Practice | Yes / No |
|---|---|
| The chairman of the board and the highest-ranking executive are from the same person | N |
| The chairman of the board is an independent director | Y |
| The chairman of the board and the highest-ranking executive are from the same family | N |
| Chairman is a member of the executive board or taskforce | N |
| The company appoints at least one independent director to determine the agenda of the board of directors’ meeting | Y |
Audit Committee
Audit Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
Scope of Authority of the Audit Committee: 1. Has the authority to invite management or employees to attend meetings for clarification, provide opinions, or submit requested documents as necessary. 2. To consider, select, and propose the appointment of independent auditors, including their remuneration, to the Board of Directors for submission to the Annual General Meeting of Shareholders, and to annually evaluate the auditors' performance. 3. To review the independence of the auditors. 4. To meet with the auditors for discussions at least once a year without the presence of management. 5. To meet with the internal auditors for discussions at least once a year without the presence of management. 6. To consider and decide in cases where management and the auditors have differing opinions regarding financial reports or there are limitations in the audit work. 7. To consider and approve significant changes in accounting principles or practices, including management's reasons. 8. To review the operating procedures and oversight of related party transactions, connected transactions, and transactions that may involve conflicts of interest to ensure compliance with relevant laws or regulations. 9. To consider reports from the Risk Management Committee and the company's management, and to discuss with management the policies for risk assessment and management. 10. To procure external advisors or professional experts to provide advice, consultation, or opinions as deemed appropriate by the Audit Committee. 11. To report to the Board of Directors for corrective action on transactions involving conflicts of interest, fraud, corruption, or deficiencies in internal controls, as well as material non-compliance with relevant laws affecting the financial position. 12. To consider the independence of the internal audit unit and to approve the appointment, transfer, or dismissal of the head of the internal audit unit or any other unit responsible for internal audit. Duties and Responsibilities of the Audit Committee: 1. To review that the company's financial reports are accurate and adequately disclosed, by coordinating with the auditors and executives responsible for preparing financial reports, both quarterly and annually. This includes reviewing the consistency of information in the financial reports with any other information related to the company's financial position and operating results communicated to investors or relevant parties, such as Management Discussion & Analysis (MD&A), Form 56-1 One Report, and company news and information. 2. To review that the company has appropriate and effective internal control and internal audit systems, by coordinating with internal auditors in preparing and reporting quarterly internal audit results, and to consider the independence of the internal audit unit (or company), as well as to approve the appointment, transfer, or dismissal of the head of the internal audit unit (or company). 3. To oversee the process for receiving whistleblowing reports from employees regarding inappropriate financial reporting or other issues. 4. To review that the company complies with securities and exchange laws, stock exchange regulations, and laws related to the company's business. 5. To prepare an Audit Committee report for submission to the Board of Directors, to be disclosed in the company's annual registration statement/annual report (Form 56-1 One Report). This report shall be signed by the Chairman of the Audit Committee and shall include the following information: Opinion on the accuracy, completeness, and reliability of the company's financial reports. Opinion on the adequacy of the company's internal control system. Opinion on compliance with securities and exchange laws. Stock exchange regulations or laws related to the company's business. Opinion on the suitability of the auditors. Opinion on transactions that may involve conflicts of interest. Number of Audit Committee meetings and attendance of each Audit Committee member. Overall opinions or observations received by the Audit Committee from performing its duties according to the charter. Any other matters that shareholders and general investors should be aware of, within the scope of duties and responsibilities assigned by the Board of Directors. Any other actions as assigned by the Board of Directors with the approval of the Audit Committee. 6. To perform any other duties as required by law, or within the scope of authority and responsibilities defined in the charter, or as assigned by the Board of Directors with the approval of the Audit Committee. Term of Office: 1. Audit Committee members shall hold office for a term of 3 years, in line with the term of office for company directors, with their term expiring at the company's Annual General Meeting of Shareholders. 2. Audit Committee members whose terms have expired may be re-appointed by the Board of Directors, but such re-appointment is not automatic and shall not exceed 3 consecutive terms. 3. Audit Committee members whose terms have expired shall remain in office to perform their duties until a replacement is appointed, unless their term as a company director has also expired and they are not re-elected as a company director. 4. In the event of a vacancy in the Audit Committee resulting in fewer than 3 members, the Board of Directors or the Shareholders' Meeting, upon the recommendation of the Nomination and Remuneration Committee, shall appoint a qualified and non-disqualified director to fill the vacancy to ensure the number of Audit Committee members meets legal requirements immediately, or at the latest within 3 months from the date the number of members becomes insufficient. The replacement Audit Committee member shall hold office only for the remaining term of the Audit Committee member they replace. 5. In addition to the expiration of the term as mentioned above, an Audit Committee member may be removed from office upon: Death. Resignation. Disqualification as an Audit Committee member or possessing prohibited characteristics according to this charter, or the Public Limited Company Act, and/or the Securities and Exchange Act. Resolution of the Board of Directors or the Shareholders' Meeting to remove them from office. Court order for removal. Cessation of directorship in the company. 6. Should any Audit Committee member wish to resign, they must submit a resignation letter to the Chairman of the Board of Directors at least 1 month in advance, stating the reasons. When an Audit Committee member resigns or is removed from office before the end of their term, the company shall immediately notify the Stock Exchange of Thailand, along with a copy of the resignation letter (in case of resignation) or the reasons (in case of removal), and submit the information to the Securities and Exchange Commission to update the database of directors and executives to reflect the actual situation. The Audit Committee member who resigns or is removed from office may also clarify the reasons to the Securities and Exchange Commission and the Stock Exchange of Thailand. | 3091 · Description: Audit of financial statements and internal controls |
Audit Committee Members
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Has Accounting or Financial Expertise? | Skills & Expertise | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Assistant Professor Dr. | Wanchai | Sutananta | Chairman of the audit committee | M | 1,960 | 643 · Description: Thailand | Y | 2020-12-09T00:00 | Doctoral degree | other | Pharmacist | N | 158 · Description: Corporate Management · 164 · Description: Strategic Management · 162 · Description: Change Management · 163 · Description: Leadership · 3173 · Description: Public Administration | 4 | 4 | 180,000 | 180,000 | 0 |
| other | Pharmacist | Worathep | Gorgitpoonpol | Audit committee | M | 1,959 | 643 · Description: Thailand | Y | 2020-12-09T00:00 | Bachelor's degree | other | Pharmacy | N | 142 · Description: Marketing · 117 · Description: Personal Products & Pharmaceuticals · 158 · Description: Corporate Management · 162 · Description: Change Management · 1683 · Description: Business Administration | 4 | 4 | 160,000 | 160,000 | 0 |
| other | Dr. | Thanadol | Ruksapol | Audit committee | M | 1,983 | 643 · Description: Thailand | Y | 2020-12-09T00:00 | Doctoral degree | Accounting | Y | 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 166 · Description: Audit · 167 · Description: Internal Control | 4 | 4 | 160,000 | 160,000 | 0 |
Audit Committee — Meeting Allowance (Baht)
500000.0
Audit Committee — Total Remuneration (Baht)
500000.0
Executive Committee
Executive Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
Powers and Duties of the Executive Committee 1. To establish policies, objectives, strategies, operational plans, annual budgets, and various management authorities of the Company and its subsidiaries for submission to the Board of Directors for approval. 2. To oversee the Company's business operations to ensure compliance with the objectives, articles of association, regulations, requirements, orders, policies, goals, strategies, operational plans, and annual budgets approved by the Board of Directors, as well as resolutions of the Board of Directors' meetings and/or shareholders' meetings, in an efficient manner conducive to the business environment. This includes providing management advice and recommendations to senior executives, and approving the appointment of various consultants necessary for the Company's operations, all within the budget approved by the Board of Directors. 3. To consider and approve normal business transactions of the Company and its subsidiaries, including capital expenditures, financial transactions with financial institutions for opening accounts, borrowing, pledging, guaranteeing, and any other matters, as well as the purchase/sale and registration of land ownership for normal transactions of the Company and its subsidiaries. This shall be within the approved financial limits as specified and/or according to the approval authority (Table of Authority) determined by the Board of Directors. 4. To define the Company's executive organizational structure and efficient management, covering the selection, training, hiring, and termination of the Company's executive or senior management personnel. The Executive Committee may delegate authority to the Chief Executive Officer, Chief Operating Officer, Managing Director, Deputy Managing Director, or Assistant Managing Director of the Company to sign employment contracts on behalf of the Company. 5. To supervise and approve matters related to the Company's operations and may appoint or assign one or more persons to act on behalf of the Executive Committee as deemed appropriate. The Executive Committee may revoke, change, or amend such authority. 6. To review and provide opinions on matters requiring approval from the Board of Directors, except for any activities that the Board of Directors has already assigned to other sub-committees. 7. To have the Company consider proposing a Company employee to serve as secretary, subject to the approval of the Board of Directors or the Executive Committee. 8. To perform any other duties assigned by the Board of Directors. However, the delegation of powers and responsibilities to the Executive Committee shall not constitute a delegation or sub-delegation of authority that would allow the Executive Committee or its delegates to approve transactions in which they, or persons who may have a conflict of interest (as defined in the notifications of the Securities and Exchange Commission), have an interest, may receive any benefit, or may have any other conflict of interest with the Company or its subsidiaries. Such approvals must be submitted to the Board of Directors' meeting and/or the shareholders' meeting of the Company and its subsidiaries, as the case may be. This exception does not apply to approvals of transactions under normal business conditions with clearly defined scopes and in accordance with policies and criteria approved by the shareholders' meeting or the Board of Directors. Term of Office 1. Executive Committee members who are also directors of the Company shall hold office and perform duties for a term of 3 years, commencing from the date of their appointment resolution. Upon completion of their term, they may be re-appointed by the Board of Directors. 2. Executive Committee members who are executives of the Company shall hold office for as long as they hold their executive positions in the Company, unless the Board of Directors resolves otherwise. 3. Executive Committee members who are external individuals not holding positions as directors or executives of the Company shall hold office for a term as deemed appropriate by the Company and may be changed as deemed appropriate by the Board of Directors. 4. In addition to the expiration of the term as mentioned above, an Executive Committee member shall vacate office upon: - Death - Resignation (If any Executive Committee member wishes to resign, a letter of resignation must be submitted to the Chairman of the Board of Directors.) - Disqualification or possessing prohibited characteristics according to this Charter or the Public Limited Company Act and/or the Securities and Exchange Act. - A resolution of the Board of Directors' meeting or the shareholders' meeting to remove them from office. - A court order for removal. 5. In the event that an Executive Committee position becomes vacant for reasons other than the expiration of the term, the Board of Directors, upon the recommendation of the Nomination and Remuneration Committee, shall appoint a qualified person without prohibited characteristics under the law to fill the vacancy. However, if the remaining term of that Executive Committee member is less than 2 months, the Board of Directors may choose not to appoint a replacement. The replacement Executive Committee member shall hold office only for the remainder of the term of the Executive Committee member they replace. 6. In the event that an Executive Committee member completes their term or is unable to serve the full term, resulting in the number of Executive Committee members falling below 3, the Board of Directors, upon the recommendation of the Nomination and Remuneration Committee, shall appoint new Executive Committee members to ensure the full complement immediately or within 3 months from the date the number of Executive Committee members becomes incomplete, in order to maintain continuity in the performance of the Executive Committee's duties. 7. To have the Company consider proposing a Company employee to serve as secretary, subject to the approval of the Board of Directors or the Executive Committee. | 3097 · Other name: Present the strategic direction, business plan, and annual budget for the Board of Directors' consideration. · Description: Others |
Executive Committee Members
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Total Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Pharmacist | Suvit | Ngampoopun | Chairman of the executive committee | M | 1,962 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Master's degree | Business Administration | 9 | 9 | 24,000 | 24,000 | 0 | |
| other | Pharmacist | Subhachai | Saibour | Member of the executive committee | M | 1,958 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Bachelor's degree | other | Pharmaceutical Sciences | 9 | 9 | 24,000 | 24,000 | 0 |
| other | Pharmacist | Somchai | Phisphahutharn | Member of the executive committee | M | 1,960 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Master's degree | Science | 9 | 9 | 24,000 | 24,000 | 0 | |
| Mr. | Surasilp | Ngampoopun | Member of the executive committee | M | 1,992 | 643 · Description: Thailand | Y | 2022-12-19T00:00 | Bachelor's degree | other | Marketing | 9 | 6 | 16,000 | 16,000 | 0 | |
| Mr. | Rachain | Sittisang | Member of the executive committee | M | 1,971 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Bachelor's degree | Business Administration | 9 | 9 | 24,000 | 24,000 | 0 | ||
| other | Pharmacist | Wongsatorn | Ngam-Anak | Member of the executive committee | M | 1,979 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Master's degree | Business Administration | 9 | 9 | 24,000 | 24,000 | 0 | |
| Ms. | Anuporn | Pattravanichkun | Member of the executive committee | F | 1,967 | 643 · Description: Thailand | Y | 2022-10-19T00:00 | Master's degree | Business Administration | 9 | 9 | 24,000 | 24,000 | 0 | ||
| other | Pharmacist | Woranuch | Kongsupapsiri | Member of the executive committee | F | 1,970 | 643 · Description: Thailand | Y | 2022-08-15T00:00 | Master's degree | other | International Business | 9 | 9 | 24,000 | 24,000 | 0 |
| Ms. | Phiraya | Chanpatya | Member of the executive committee | F | 1,989 | 643 · Description: Thailand | Y | 2022-11-14T00:00 | Bachelor's degree | Accounting | 9 | 9 | 24,000 | 24,000 | 0 | ||
| Mr. | Pakorn | Thongklawe | Member of the executive committee | M | 1,990 | 643 · Description: Thailand | Y | 2022-11-14T00:00 | Bachelor's degree | Accounting | 9 | 9 | 24,000 | 24,000 | 0 | ||
| other | Pharmacist | Tira | Thanajirawat | Member of the executive committee | M | 1,965 | 643 · Description: Thailand | Y | 2025-03-11T00:00 | Master's degree | Business Administration | 6 | 6 | 24,000 | 24,000 | 0 |
Executive Committee — Meeting Allowance (Baht)
256000.0
Executive Committee — Total Remuneration (Baht)
256000.0
Other Subcommittees
Other Subcommittees
| Subcommittee Name | Type of Subcommittee | Roles, Duties and Responsibilities | Meetings Held | Subcommittee Remuneration | Members |
|---|---|---|---|---|---|
| Nomination and Remuneration Committee | 3093 · Description: Director and executive nomination · 3094 · Description: Remuneration | Duties and Responsibilities of the Nomination and Remuneration Committee 1. Nomination (1) Establish criteria and policies for the nomination of directors, considering the appropriateness of the number, structure, and composition of the Board of Directors, and define qualifications for directors, to be proposed to the Board of Directors and/or submitted for approval at the Shareholders' Meeting, as the case may be. (2) Consider, select, and propose suitable individuals to serve as directors or sub-committee members to replace those whose terms have expired, and/or when a vacancy arises, and/or for additional appointments. (3) Consider the qualifications of the Chief Executive Officer suitable for the company's business management to achieve the defined vision, covering education, experience, knowledge, and expertise, and incorporate significant and relevant business environmental factors, such as economic and industry conditions and trends, as well as business competition, into the consideration. (4) Prepare and review the Succession Plan for the company's Chief Executive Officer to ensure continuous readiness for successors, so that the company's operations can proceed without interruption, to be proposed to the Board of Directors for approval. (5) Evaluate the performance of the Board of Directors, sub-committees, and the company's Chief Executive Officer to provide recommendations to the Board of Directors meeting for appropriate remuneration consideration. 2. Remuneration Determination (1) Establish criteria and policies for determining remuneration for the Board of Directors, sub-committees, and C-Level executives, to be proposed to the Board of Directors and/or submitted for approval at the Shareholders' Meeting, as the case may be. (2) Determine necessary and appropriate remuneration, both monetary and non-monetary, for individual members of the Board of Directors, sub-committees, and C-Level executives. The determination of remuneration for the Board of Directors, sub-committees, and C-Level executives shall consider the appropriateness of duties, responsibilities, performance, and comparison with companies in similar businesses, by linking remuneration to the overall performance of the company to attract and retain capable, qualified, and high-potential directors, sub-committee members, and C-Level executives, to be proposed to the Board of Directors for consideration and approval, and/or submitted to the Shareholders' Meeting for approval, as the case may be. (3) Establish criteria and methods for performance evaluation of the Board of Directors, sub-committees, and the Chief Executive Officer, and have the duty to provide explanations and answer questions regarding directors' remuneration at the Shareholders' Meeting. (4) Report on policies, principles/reasons for determining remuneration for directors, sub-committee members, the Chief Executive Officer, and C-Level executives in accordance with the regulations of the Stock Exchange of Thailand, by disclosing it in the company's Annual Registration Statement / Annual Report (Form 56-1 One Report). 3. Have the authority to assign the management and various departments to undertake any actions to support the operations of the Nomination and Remuneration Committee to fulfill the duties and responsibilities specified in this Charter, or any other special duties as assigned by the Board of Directors and approved by the Nomination and Remuneration Committee. 4. Perform any other duties as prescribed by law, or within the scope of duties and responsibilities defined in the Charter, or as assigned by the Board of Directors and with the approval of the Nomination and Remuneration Committee. Term of Office 1. Members of the Nomination and Remuneration Committee shall hold office for a term of 3 years, with their terms expiring in rotation with the terms of the company's directors. 2. Members of the Nomination and Remuneration Committee whose terms have expired are eligible for re-appointment if approved by the Board of Directors or the Shareholders' Meeting (as the case may be). 3. In addition to vacating office upon term expiration, members of the Nomination and Remuneration Committee may vacate office when: • Their status as a company director ceases. • Deceased. • Resigns. • Lacks qualifications to be a member of the Nomination and Remuneration Committee or possesses prohibited characteristics under this Charter or under the Public Limited Company Act and/or the Securities and Exchange Act. • The Board of Directors or the Shareholders' Meeting resolves to remove them from office. • A court order for removal is issued. 4. A member of the Nomination and Remuneration Committee wishing to resign shall submit a resignation letter to the Chairman of the Board of Directors at least 1 month in advance, stating the reasons. 5. In the event that a position on the Nomination and Remuneration Committee becomes vacant for reasons other than term expiration, resulting in the number of Nomination and Remuneration Committee members being less than 3, the Board of Directors or the Shareholders' Meeting (as the case may be), upon the recommendation of the Nomination and Remuneration Committee, shall select a qualified director without prohibited characteristics to become a member of the Nomination and Remuneration Committee. The replacement member of the Nomination and Remuneration Committee shall hold office only for the remaining term of the member they replace. | 2 | 150000.0 · Meeting allowance: 150000.0 | 263 · Last name: Sutananta · Position: 37 · First name: Wanchai · Total meeting: 2 · Title other name: Assistant Professor Dr. · Meeting allowance: 80000.0 · Total remuneration: 80000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · 263 · Last name: Gorgitpoonpol · Position: 39 · First name: Worathep · Total meeting: 2 · Title other name: Pharmacist · Meeting allowance: 70000.0 · Total remuneration: 70000.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · 263 · Last name: Ngampoopun · Position: 39 · First name: Suvit · Total meeting: 2 · Title other name: Pharmacist · Total meeting attendance: 2 · Non monetary remuneration: 0 |
| Risk Management Committee | 3092 · Description: Risk management | Powers, Duties, and Responsibilities of the Risk Management Committee 1. Define and review policies, objectives, and the enterprise-wide risk management framework, encompassing both Integrated Risk Management and key business risks such as Strategic Risk, Business Risk, Operational Risk, Compliance Risk, including corruption and ESG Risk (Environmental, Social, and Governance issues), as well as Emerging Risks. This is to ensure effectiveness in business operations, adherence to international standards, and alignment with operational strategies, business plans, and changing circumstances over time. 2. Consider and provide opinions on the draft enterprise risk management policy and framework before submitting them to the Board of Directors for consideration, feedback, and approval. 3. Consider and provide opinions on the results of risk assessments, approaches, risk management measures, and action plans for the company's risk prevention, to ensure that the company has adequate and appropriate risk management. 4. Oversee and support the successful implementation of enterprise risk management, recommend prevention methods and ways to reduce risk to an acceptable level, and continuously monitor risk reduction action plans, appropriate to business conditions, to ensure that risks are adequately and appropriately managed. 5. Have the authority to assign tasks to the management or appoint working groups to perform any necessary actions to support the Risk Management Committee in fulfilling its duties and responsibilities as defined in this charter, or any other special duties as assigned by the Committee and approved by the Board of Directors. 6. Provide advice and support to the Board of Directors, management, and risk management working groups on enterprise-level risk management, including promoting and supporting continuous and consistent improvement and development of the internal risk management system. 7. Oversee and support the regular review and revision of the enterprise risk management policy and framework at least annually, to ensure that such policies and frameworks remain consistent and appropriate with the overall business operations and the company's risk management activities. 8. Regularly report significant organizational risks, including the status of risks, risk management approaches, progress, and results of risk management, to the Board of Directors for their acknowledgment. 9. Perform any other duties as required by law, or within the scope of powers, duties, and responsibilities defined in the charter, or as assigned by the Board of Directors with the approval of the Risk Management Committee. Term of Office 1. Risk Management Committee members who are also company directors shall hold office for a term of 3 years, in accordance with the term of office for company directors, with rotation based on the director's term. 2. Risk Management Committee members who are executives or employees of the company shall hold office for a term of 3 years from the date of appointment, unless the Board of Directors resolves otherwise. 3. Risk Management Committee members who are external individuals not holding positions as company directors or executives shall hold office for a term of 3 years from the date of appointment. 4. Risk Management Committee members whose terms have expired are eligible for re-appointment if approved by the Board of Directors or the Shareholders' Meeting, upon the recommendation of the Nomination and Remuneration Committee. 5. In addition to the expiration of their term, Risk Management Committee members may be removed from office when: • Their status as a company director ceases (for Risk Management Committee members who are company directors). • Death. • Resignation. • Disqualification as a Risk Management Committee member or possessing prohibited characteristics according to this charter or the Public Limited Company Act and/or the Securities and Exchange Act. • The Board of Directors or the Shareholders' Meeting resolves to remove them from office. • A court order for removal. 6. A Risk Management Committee member wishing to resign must submit a resignation letter to the Chairman of the Board of Directors at least 1 month in advance, stating the reasons. 7. In the event that a Risk Management Committee position becomes vacant for reasons other than the expiration of the term, resulting in the number of Risk Management Committee members falling below 3, the Board of Directors or the Shareholders' Meeting (as the case may be), upon the recommendation of the Nomination and Remuneration Committee, shall select a qualified and non-prohibited director to fill the vacant Risk Management Committee position. The replacement Risk Management Committee member shall serve only for the remaining term of the member they are replacing. | 4 | 180000.0 · Meeting allowance: 180000.0 | 263 · Last name: Ruksapol · Position: 37 · First name: Thanadol · Total meeting: 4 · Title other name: Dr. · Meeting allowance: 180000.0 · Total remuneration: 180000.0 · Total meeting attendance: 4 · Non monetary remuneration: 0 · 263 · Last name: Saibour · Position: 39 · First name: Subhachai · Total meeting: 4 · Title other name: Pharmacist · Total meeting attendance: 4 · Non monetary remuneration: 0 · 263 · Last name: Phisphahutharn · Position: 39 · First name: Somchai · Total meeting: 4 · Title other name: Pharmacist · Total meeting attendance: 4 · Non monetary remuneration: 0 |
Executives
Names and Positions — Introduction
In addition to the Board of Directors and sub-committees, the Company has appointed senior executives to support the operations of the Board of Directors, as listed below:
List of Executives | Position |
1. Mr. Suvit Ngamphuphan | Chief Executive Officer |
2. Mr. Subhachai Saibua | Chief Operating Officer |
3. Mr. Somchai Pisapahutharn | Chief Accounting and Finance Officer |
4. Ms. Anuporn Pattarawanichyakul | Director of Finance |
5. Ms. Phiraya Chanpatya | Assistant Chief Accounting and Finance Officer |
6. Mr. Pakorn Thongklawe | Assistant Chief Accounting and Finance Officer |
7. Ms. Woranuch Kongsupapsiri | Director of Marketing |
8. Mr. Wongsathorn Ngam-anak | Director of Support Operations |
9. Mr. Rachain Sittisang | Director of Production |
10. Mr. Alongkorn Leela-Uppatikarn | Assistant Chief Operating Officer |
11. Ms. Narinthorn Buranapreecha | Director of Innovation, Legal Registration, and Intellectual Property |
Note:
1. Mr. Alongkorn Leela-Uppatikarn concluded his duties as Assistant Chief Operating Officer on March 31, 2025.
2. Ms. Narintorn Buranapreecha was appointed as Director of Innovation, Legal Registration, and Intellectual Property on April 1, 2025.
Executives
| Title | Title — Please Specify | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Is the Highest-ranking Executive? | Is the Highest-ranking Accounting or Finance Officer? | Directly Responsible for Accounting? | Appointed After the End of the Fiscal Year? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| other | Pharmacist | Suvit | Ngampoopun | Chief Executive Officer | M | 1,962 | 643 · Description: Thailand | Y | 1992-10-16T00:00 | Master's degree | Business Administration | 142 · Description: Marketing · 164 · Description: Strategic Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals · 163 · Description: Leadership | Y | N | N | N | |
| other | Pharmacist | Subhachai | Saibour | Chief Operations Officer | M | 1,958 | 643 · Description: Thailand | Y | 1992-10-16T00:00 | Bachelor's degree | other | Pharmaceutical Sciences | 1683 · Description: Business Administration · 158 · Description: Corporate Management · 117 · Description: Personal Products & Pharmaceuticals · 145 · Description: Corporate Social Responsibility · 164 · Description: Strategic Management | N | N | N | N |
| other | Pharmacist | Somchai | Phisphahutharn | Chief Accounting and Finance Officer | M | 1,960 | 643 · Description: Thailand | Y | 1992-10-16T00:00 | Master's degree | Science | 143 · Description: Accounting · 144 · Description: Finance · 117 · Description: Personal Products & Pharmaceuticals · 158 · Description: Corporate Management · 165 · Description: Risk Management | N | Y | N | N | |
| Ms. | Anuporn | Pattravanichkun | Director of Finance | F | 1,967 | 643 · Description: Thailand | Y | 2021-01-01T00:00 | Master's degree | Business Administration | 144 · Description: Finance · 143 · Description: Accounting · 145 · Description: Corporate Social Responsibility · 146 · Description: Human Resource Management · 163 · Description: Leadership | N | N | N | N | ||
| Ms. | Phiraya | Chanpatya | Assistant Chief Accounting and Finance Officer | F | 1,989 | 643 · Description: Thailand | Y | 2022-04-18T00:00 | Bachelor's degree | Accounting | 143 · Description: Accounting · 168 · Description: Budgeting · 144 · Description: Finance · 152 · Description: Data Analysis · 165 · Description: Risk Management | N | N | Y | N | ||
| Mr. | Pakorn | Thongklawe | Assistant Chief Accounting and Finance Officer | M | 1,990 | 643 · Description: Thailand | Y | 2022-03-16T00:00 | Bachelor's degree | Accounting | 143 · Description: Accounting · 168 · Description: Budgeting | N | N | N | N | ||
| other | Pharmacist | Woranuch | Kongsupapsiri | Marketing Director | F | 1,970 | 643 · Description: Thailand | Y | 2022-02-01T00:00 | Master's degree | other | International Business | 1683 · Description: Business Administration · 142 · Description: Marketing · 155 · Description: Brand Management · 164 · Description: Strategic Management | N | N | N | N |
| other | Pharmacist | Wongsatorn | Ngam-Anak | Director of Support Functions | M | 1,979 | 643 · Description: Thailand | Y | 2021-02-10T00:00 | Master's degree | Business Administration | 117 · Description: Personal Products & Pharmaceuticals · 146 · Description: Human Resource Management · 147 · Description: Sustainability · 150 · Description: IT Management | N | N | N | N | |
| Mr. | Rachain | Sittisang | Production Director | M | 1,971 | 643 · Description: Thailand | Y | 2021-02-10T00:00 | Bachelor's degree | Business Administration | 1683 · Description: Business Administration · 138 · Description: Transportation & Logistics · 148 · Description: Procurement · 157 · Description: Project Management · 165 · Description: Risk Management | N | N | N | N | ||
| other | Pharmacist | Alongkorn | Leela-Uppatikarn | Assistant Chief Operations Officer | M | 1,969 | 643 · Description: Thailand | Y | 2021-12-21T00:00 | Master's degree | Business Administration | 134 · Description: Health Care Services · 1683 · Description: Business Administration · 165 · Description: Risk Management | N | N | N | N | |
| other | Pharmacist | Narinthorn | Buranapreecha | Director of Innovation, Legal Registration, and Intellectual Property | F | 1,984 | 643 · Description: Thailand | Y | 2025-04-01T00:00 | Doctoral degree | other | Pharmaceutical Sciences | 165 · Description: Risk Management · 117 · Description: Personal Products & Pharmaceuticals · 152 · Description: Data Analysis · 161 · Description: Design | N | N | N | N |
Executive Remuneration
Monetary Remuneration — Description
The compensation for the Chief Executive Officer and the executive committee, totaling 10 persons, amounts to 33,304,010.69 million Baht Comprising salaries, bonuses, and other compensation.
Other compensation includes social security contributions, provident fund contributions at a rate of 3%, overtime pay, vacation leave compensation, and personal insurance premiums (including Incentive + car allowance + retroactive).
Monetary Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total remuneration of executive directors and executives (baht) | 33,304,010.69 | 32,250,000 | 31,360,000 |
| Total remuneration of executive directors (baht) | |||
| Total remuneration of executives (baht) |
Other Remuneration
| Metric |
|---|
| Company’s contribution to provident fund for executive directors and executives (Baht) |
| Employee Stock Ownership Plan (ESOP) |
| Employee Joint Investment Program (EJIP) |
Remuneration or Benefits Payable to Executives
| Metric | Amount (Baht) |
|---|---|
| Outstanding remuneration or benefits of executive directors and executives in the past year (baht) | 0 |
| Estimated remuneration of executive directors and executives in the current year (baht) | 0 |
Remuneration Policy
Executive Remuneration Policy
The remuneration for the Board of Directors and sub-committees must be approved by the Shareholders' Meeting, with the opinion of the Nomination and Remuneration Committee. The Nomination and Remuneration Committee provides its opinion that the remuneration determination has considered the roles, duties, responsibilities, performance, and operating results of the company, together with benchmarking against the remuneration of directors in similar industries. Therefore, it is proposed to the Board of Directors for consideration of the remuneration for the Board of Directors and sub-committees. The Board of Directors shall approve the remuneration of the Chief Executive Officer in line with their performance, with the opinion of the Nomination and Remuneration Committee. The Chief Executive Officer shall consider the remuneration for executives, and will consider and propose remuneration (both monetary and non-monetary), including other benefits, as appropriate for their duties, responsibilities, performance, and the company's operating results. The consideration of remuneration must take into account long-term incentives and should not be excessively high to the point of focusing solely on short-term performance. Furthermore, executive remuneration each year will be paid within the annual budget framework, which has been considered and approved by the Board of Directors.
Determination of Directors' Remuneration
1. The Nomination and Remuneration Committee considers directors' remuneration based on their knowledge, abilities, duties, and responsibilities for each position, their individual and collective performance in the past year, alignment with business expansion, the company's operating results, and profit growth, benchmarked against the remuneration of directors in similar industries of comparable size.
2. The Nomination and Remuneration Committee may propose that directors are entitled to receive remuneration from the company in the form of a retainer fee, performance-based incentive, and attendance fee.
3. The Board of Directors shall annually survey and review the appropriateness of the criteria and remuneration for directors and sub-committee members, providing its opinion on the determination of such remuneration based on the recommendations of the Nomination and Remuneration Committee, before submitting it to the Shareholders' Meeting for further consideration and approval.
Determination of Senior Executive Remuneration
1. The Nomination and Remuneration Committee considers the remuneration of senior executives based on their knowledge, abilities, duties, and responsibilities, their performance in the past year, the company's business operations, adherence to policies received from the Board, management under economic and social conditions, ability to develop the business, and annual improvements in operational efficiency, benchmarked against the remuneration of executives in similar industries of comparable size, which can incentivize them.
2. The Nomination and Remuneration Committee may propose that senior executives are entitled to receive remuneration from the company in the form of salaries, rewards, bonuses, or other types of remuneration benefits, as well as allowances and other welfare benefits as deemed appropriate.
3. The Nomination and Remuneration Committee shall review the appropriateness of the criteria and remuneration for senior executives annually and provide its opinion before submitting it to the Board of Directors for further consideration and approval.
The remuneration for the company's executives comprises salaries, bonuses, and other benefits such as social security contributions, provident fund contributions, etc.
Was an Opinion Obtained from the Board and the Remuneration Committee?
No
Employees
Any Significant Change in Headcount in the Past 3 Years?
No
Provident Fund
Does the Company Have a Provident Fund?
No
Policy for Employees Not in the Provident Fund
Automatic Enrolment
No
Encouraging Retirement Saving
No
Providing Investment Information
No
Other Measures
No
Auditors and Audit Fees
How Audit Fees Are Reported
SEPERATE
Company Auditor and Fees
| Audit Firm | Sub-district | District | Province | Postcode | Fax | Auditors | Audit Fee (Baht) | Any Non-audit Fee? | Type of Non-audit Service | Non-audit Service Details | Non-audit Fee (Baht) | Amount Paid During the Year (Baht) | Amount Payable in Future (Baht) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPMG PHOOMCHAI AUDIT COMPANY LIMITED | YAN NAWA | SATHON | Bangkok | 10120 | 0 2677 2222 | Bunyarit@kpmg.co.th · Title: 260 · Regis no: 7900 · Last name: THANORMCHAROEN · First name: BUNYARIT · sirinuchv@kpmg.co.th · Title: 261 · Regis no: 8413 · Last name: SURAPAITOONKORN · First name: SIRINUCH · sumate@kpmg.co.th · Title: 260 · Regis no: 9362 · Last name: JANGSAMSEE · First name: SUMATE · yoottapong@kpmg.co.th · Title: 260 · Regis no: 10604 · Last name: SOONTALINKA · First name: YOOTTAPONG | 2,840,000 | Y | The observation of stock destruction / Preparation of Transfer Pricing Report | In 2025, the Company engaged the auditor to observe the annual inventory destruction and engaged an affiliate of the audit firm to prepare a local comparative analysis report to determine an arm's length price range in accordance with market principles. | 688,000 | 204,000 | 484,000 |
How Subsidiary Audit Information Is Reported
AUDITOR_AND_FEE
Subsidiary Auditors and Fees
| Audit Firm | Sub-district | District | Province | Postcode | Fax | Auditors | Audit Fee (Baht) | Any Non-audit Fee? | Type of Non-audit Service | Non-audit Service Details | Non-audit Fee (Baht) | Amount Paid During the Year (Baht) | Amount Payable in Future (Baht) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPMG PHOOMCHAI AUDIT COMPANY LIMITED | YAN NAWA | SATHON | Bangkok | 10120 | 0 2677 2222 | Bunyarit@kpmg.co.th · Title: 260 · Regis no: 7900 · Last name: THANORMCHAROEN · First name: BUNYARIT · sirinuchv@kpmg.co.th · Title: 261 · Regis no: 8413 · Last name: SURAPAITOONKORN · First name: SIRINUCH · sumate@kpmg.co.th · Title: 260 · Regis no: 9362 · Last name: JANGSAMSEE · First name: SUMATE · yoottapong@kpmg.co.th · Title: 260 · Regis no: 10604 · Last name: SOONTALINKA · First name: YOOTTAPONG | 3,020,000 | Y | The observation of stock destruction | In 2025, the Company engaged the auditor to observe the annual inventory destruction. | 16,000 | 0 | 16,000 |
Company Secretary and Other Assigned Persons
Company Secretary
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | pattarnan | Choowangcha | pattarnan@bangkoklab.co.th | 032-719900 |
Chief Accountant
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Phiraya | Chanpatya | Phiraya.c@pharmaalliance.co.th | 032-719900 |
Head of Internal Audit
| Title | First Name | Last Name | |
|---|---|---|---|
| Ms. | Anatsaya | Raksasorn | anutsaya@dir.co.th |
Investor Relations Contact
Does the Company Have an Investor Relations Contact?
Yes
Investor Relations Contacts
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Mr. | Pakorn | Thongklawe | ir@blcplc.com | 091-7735757, 097-1906336 |
Head of Investor Relations — Introduction
The Board of Directors oversees the management to ensure that Investor Relations personnel are responsible for communicating with shareholders and other stakeholders, such as investors and analysts, in an appropriate, equitable, and timely manner. Currently, there is one person responsible for Investor Relations, as follows:
Representatives in Thailand (Foreign Companies)
Does the Company Have Representatives in Thailand?
No

